ICCT:NSD-iCoreConnect Inc. Common stock (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 2.799

Change

+2.68 (+2,248.15)%

Market Cap

USD 2.90M

Volume

0.50M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.20 (-0.30%)

USD 10.78B
DOCS Doximity Inc

+0.35 (+0.61%)

USD 10.37B
WEAV Weave Communications Inc

+0.07 (+0.43%)

USD 1.13B
AMWL American Well Corp

-0.43 (-5.46%)

USD 0.15B
MPLN MultiPlan Corporation

+0.26 (+4.32%)

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.08B
VEEV Veeva Systems Inc Class A

+0.74 (+0.33%)

N/A
PHR Phreesia Inc

+0.22 (+0.87%)

N/A
FOXO FOXO Technologies Inc.

-0.01 (-1.96%)

N/A
EVH Evolent Health Inc

-0.09 (-0.79%)

N/A

ETFs Containing ICCT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -88.71% 18% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.71% 18% F 1% F
Trailing 12 Months  
Capital Gain -90.41% 18% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -90.41% 18% F 1% F
Trailing 5 Years  
Capital Gain -99.48% 20% F N/A F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.48% 20% F N/A F
Average Annual (5 Year Horizon)  
Capital Gain 381.03% 97% N/A 96% N/A
Dividend Return 381.03% 97% N/A 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,066.11% 5% F 5% F
Risk Adjusted Return 35.74% 85% B 67% D+
Market Capitalization 2.90M 14% F 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.